CytoMed Therapeutics Ltd. Files Form 6-K
Ticker: GDTC · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, corporate-update
TL;DR
CytoMed Therapeutics Ltd. filed a 6-K on Nov 20, 2024, updating its status as a foreign private issuer.
AI Summary
On November 20, 2024, CytoMed Therapeutics Limited issued a press release. The company's former name was CytoMed Therapeutics Pte. Ltd., with a name change occurring on July 16, 2021. The filing is a Report of Foreign Private Issuer.
Why It Matters
This filing indicates routine corporate updates and reporting for CytoMed Therapeutics Limited as a foreign private issuer, providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a standard procedural report for a foreign private issuer and does not contain new financial or operational information that would indicate increased risk.
Key Numbers
- 11/20/2024 — Filing Date (Date the 6-K report was filed with the SEC.)
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Filer of the 6-K report
- CytoMed Therapeutics Pte. Ltd. (company) — Former name of the registrant
- 20241120 (date) — Date of filing and report period
- 001-41677 (other) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange.
When was CytoMed Therapeutics Limited previously known by another name?
CytoMed Therapeutics Limited was formerly known as CytoMed Therapeutics Pte. Ltd., with a date of name change on July 16, 2021.
What is the principal executive office address of CytoMed Therapeutics Limited?
The principal executive office is located at 1 Commonwealth Lane #08-22, Singapore 149544.
What is the SIC code for CytoMed Therapeutics Limited?
The Standard Industrial Classification (SIC) code for CytoMed Therapeutics Limited is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for CytoMed Therapeutics Limited?
The SEC file number for CytoMed Therapeutics Limited is 001-41677.
Filing Stats: 313 words · 1 min read · ~1 pages · Grade level 15.4 · Accepted 2024-11-20 07:00:12
Filing Documents
- form6-k.htm (6-K) — 20KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-046929.txt ( ) — 43KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CytoMed Therapeutics Limited Date: November 20, 2024 By: /s/ CHOO Chee Kong CHOO Chee Kong Director and Chairman